| Juan Esteban Rey Rueda, MD | |
|
3540 W Sahara Ave # 330, Las Vegas, NV 89102-5816 | |
| (725) 217-8555 | |
| (702) 259-1252 |
| Full Name | Juan Esteban Rey Rueda |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 3540 W Sahara Ave # 330, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043661622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 19249 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Hills Hospital And Medical Center | Las vegas, NV | Hospital |
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pioneer Health Care Llc | 3577560457 | 28 |
News Archive
Researchers at Center for BrainHealth, part of The University of Texas at Dallas, collaborated with scientists at the University of North Carolina at Chapel Hill to examine whether the Strategic Memory Advanced Reasoning Training (SMART) program affects people's abilities to make informed decisions about their medical treatment options.
In a new study, published in this week's issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli.
Gilead Sciences, Inc. today announced that it has dosed the first patient in the Phase III clinical program evaluating its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat (formerly GS 9350), emtricitabine and tenofovir disoproxil fumarate.
Researchers have developed a new mouse model that could be used in Zika research to better understand the virus and find new treatments, according to a study published in PLOS Pathogens.
Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia, provided patients with quicker, better responses as a first therapy than the existing front-line drug, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Entity Name | Pioneer Health Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588681332 PECOS PAC ID: 3577560457 Enrollment ID: O20061107000417 |
News Archive
Researchers at Center for BrainHealth, part of The University of Texas at Dallas, collaborated with scientists at the University of North Carolina at Chapel Hill to examine whether the Strategic Memory Advanced Reasoning Training (SMART) program affects people's abilities to make informed decisions about their medical treatment options.
In a new study, published in this week's issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli.
Gilead Sciences, Inc. today announced that it has dosed the first patient in the Phase III clinical program evaluating its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat (formerly GS 9350), emtricitabine and tenofovir disoproxil fumarate.
Researchers have developed a new mouse model that could be used in Zika research to better understand the virus and find new treatments, according to a study published in PLOS Pathogens.
Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia, provided patients with quicker, better responses as a first therapy than the existing front-line drug, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Esteban Rey Rueda, MD 3540 W Sahara Ave # 330, Las Vegas, NV 89102-5816 Ph: (725) 217-8555 | Juan Esteban Rey Rueda, MD 3540 W Sahara Ave # 330, Las Vegas, NV 89102-5816 Ph: (725) 217-8555 |
News Archive
Researchers at Center for BrainHealth, part of The University of Texas at Dallas, collaborated with scientists at the University of North Carolina at Chapel Hill to examine whether the Strategic Memory Advanced Reasoning Training (SMART) program affects people's abilities to make informed decisions about their medical treatment options.
In a new study, published in this week's issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli.
Gilead Sciences, Inc. today announced that it has dosed the first patient in the Phase III clinical program evaluating its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat (formerly GS 9350), emtricitabine and tenofovir disoproxil fumarate.
Researchers have developed a new mouse model that could be used in Zika research to better understand the virus and find new treatments, according to a study published in PLOS Pathogens.
Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia, provided patients with quicker, better responses as a first therapy than the existing front-line drug, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
Dr. Vinod Korrapati, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2720 N Tenaya Way, Las Vegas, NV 89128 Phone: 419-865-3040 Fax: 702-560-2928 | |
Miss Nasibo Hassan Kadir, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8280 W Warm Springs Rd, Las Vegas, NV 89113 Phone: 702-492-8592 Fax: 702-492-8045 | |
Nicholas Kalayeh, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 4275 Burnham Ave, Ste 220, Las Vegas, NV 89119 Phone: 702-796-4278 Fax: 702-737-9286 | |
Mir A Majeed, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 8280 W Warm Springs Rd, Las Vegas, NV 89113 Phone: 702-921-6829 Fax: 702-921-6828 | |
Dr. Monsuru O Ibraheem, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6970 W. Patrick Lane, Suite 140, Las Vegas, NV 89113 Phone: 702-450-1717 Fax: 702-947-6740 | |
Sameer Tapryal, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 S Rainbow Blvd, Hcpnv Inpatient Team, Las Vegas, NV 89145 Phone: 702-952-9171 Fax: 702-952-9136 |